71370988 :
@Trytosaveabit I’m stuck on this with the 10.82 avg after the RS, is it worth bringing the average down? I meant any hope for this to be reversed?
Trytosaveabitスレ主71370988:
I need to dig in a bit deeper! Can’t remember dates for possible pipeline catalysts? But I do remember that I do like it as a swing! I just can’t remember the dates! I look at way to many and without looking in my notes I forget!
$ニューカナ(NCNA.US)$NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study NUC-7738 Reprograms Cancer Cell Lipid Metabolism to Make Tumors Less Aggressive and Promote Cancer Cell Death NUC-7738 Alters Ribosome Biogenesis and the Regulation of Genes Critical for Cancer Growth and Survival San Diego, California April 9, 2024 (GLOBE NEWSWIRE)- NuCana plc (NASDAQ: NCNA) announced two posters be...
$ニューカナ(NCNA.US)$ NEWS NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study NuCana plc (NASDAQ: NCNA) presented two posters at the AACR Annual Meeting showcasing the effects of NUC-7738 on cancer cell lipid metabolism and ribosome biogenesis. NUC-7738 was found to reprogram lipid metabolism in tumors, making them less aggressive and promoting cancer cell death. The drug alters genes critica...
ニューカナに関するコメント
NEWS
NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement
Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy
Clinical Study
NUC-7738 Reprograms Cancer Cell Lipid Metabolism to Make Tumors Less Aggressive
and Promote Cancer Cell Death
NUC-7738 Alters Ribosome Biogenesis and the Regulation of Genes Critical for Cancer
Growth and Survival
San Diego, California April 9, 2024 (GLOBE NEWSWIRE)- NuCana plc (NASDAQ: NCNA) announced two posters be...
NEWS
NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study
NuCana plc (NASDAQ: NCNA) presented two posters at the AACR Annual Meeting showcasing the effects of NUC-7738 on cancer cell lipid metabolism and ribosome biogenesis. NUC-7738 was found to reprogram lipid metabolism in tumors, making them less aggressive and promoting cancer cell death. The drug alters genes critica...
まだコメントはありません